FDA approves new type of non-opioid pain medication in two decades - The new drug will be many times more expensive than a ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
CNBC’s Angelica Peebles and Vertex JournavxPharmaceuticals CEO Reshma Kewalramani join 'Squawk on the Street' to discuss the ...
The company announced that the Food and Drug Administration (FDA) has approved Journavx, a twice-daily pill that it described as a "highly selective NaV1.8 pain signal inhibitor for the treatment of ...